Literature DB >> 16901590

The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection.

María Morell1, M Carmen Thomas, Trinidad Caballero, Carlos Alonso, Manuel C López.   

Abstract

The immunological properties of the Trypanosoma cruzi paraflagellar rod proteins (PFR2 and PFR3) administered alone as well as fused to HSP70 have been analyzed in mice in the context of genetic immunization. The immunization of mice with the DNA vectors containing the PFRs gene or PFRs-HSP70 fused genes induced high level of IgG(2a) anti-PFRs. However, only the immunization with the PFR2-HSP70 fused genes triggers in spleen cells a statistically significant enhancement of expression of IL-12 and IFN-gamma and a decrease in the percentage of cells expressing IL-4. Likewise, the PFR2-HSP70 molecule elicits a statistically significant activation of PFR2 antigen specific CTLs. Immunization with the PFR2-HSP70 chimeric gene provided a protective response against a T. cruzi experimental infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901590     DOI: 10.1016/j.vaccine.2006.07.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.

Authors:  Anil Kumar Jaiswal; Prashant Khare; Sumit Joshi; Pramod Kumar Kushawaha; Shyam Sundar; Anuradha Dube
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 2.  The paraflagellar rod of kinetoplastid parasites: from structure to components and function.

Authors:  Neil Portman; Keith Gull
Journal:  Int J Parasitol       Date:  2009-10-30       Impact factor: 3.981

3.  Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.

Authors:  Eduardo L V Silveira; Carla Claser; Filipe A B Haolla; Luiz G Zanella; Mauricio M Rodrigues
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

4.  Short-term follow-up of chagasic patients after benzonidazole treatment using multiple serological markers.

Authors:  Ana Fernández-Villegas; María Jesús Pinazo; Concepción Marañón; M Carmen Thomas; Elizabeth Posada; Bartolomé Carrilero; Manuel Segovia; Joaquim Gascon; Manuel C López
Journal:  BMC Infect Dis       Date:  2011-07-31       Impact factor: 3.090

5.  A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas disease.

Authors:  Minerva Arce-Fonseca; Angel Ramos-Ligonio; Aracely López-Monteón; Berenice Salgado-Jiménez; Patricia Talamás-Rohana; José Luis Rosales-Encina
Journal:  Int J Biol Sci       Date:  2011-10-25       Impact factor: 6.580

Review 6.  Prophylactic and therapeutic DNA vaccines against Chagas disease.

Authors:  Minerva Arce-Fonseca; Martha Rios-Castro; Silvia del Carmen Carrillo-Sánchez; Mariana Martínez-Cruz; Olivia Rodríguez-Morales
Journal:  Parasit Vectors       Date:  2015-02-24       Impact factor: 3.876

7.  Phenotypic and Functional Profiles of Antigen-Specific CD4+ and CD8+ T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis.

Authors:  Adriana Egui; Darién Ledesma; Elena Pérez-Antón; Andrés Montoya; Inmaculada Gómez; Sara María Robledo; Juan José Infante; Ivan Darío Vélez; Manuel C López; M Carmen Thomas
Journal:  Front Cell Infect Microbiol       Date:  2018-11-19       Impact factor: 5.293

Review 8.  T Cell Specificity: A Great Challenge in Chagas Disease.

Authors:  Fátima Ferragut; Gonzalo R Acevedo; Karina A Gómez
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

9.  Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi.

Authors:  Raquel Tayar Nogueira; Alanderson Rocha Nogueira; Mirian Claudia Souza Pereira; Maurício Martins Rodrigues; Patrícia Cristina da Costa Neves; Ricardo Galler; Myrna Cristina Bonaldo
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

Authors:  Augusto E Bivona; Andrés Sánchez Alberti; Marina N Matos; Natacha Cerny; Alejandro C Cardoso; Celina Morales; Germán González; Silvia I Cazorla; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.